Navigation Links
Positive Phase 2 Results Reported with Boehringer Ingelheim's Investigational HCV Protease Inhibitor in Both Previously Treated and Untreated Patients
Date:4/1/2011

gated hyperbilirubinemia.  Average alanine aminotransferase (ALT) improved in all BI 201335 groups compared to placebo, and there was no excess anemia reported in the study.  Across BI 201335 treatment groups, 4 to 12 percent of patients discontinued BI 201335 due to AEs.  

(Oral abstract #66) SILEN-C2: Sustained Virologic Response and Safety of BI 201335 Combined with Peginterferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Patients with Non-Response to PegIFN/RBVThe SILEN-C2 study evaluated the virological response and safety of different doses of BI 201335 in treatment-experienced patients who did not respond to at least 12 weeks of prior treatment with PegIFN/RBV. This patient population is particularly difficult to treat, as patients who have not responded to PegIFN/RBV alone have low response rates to additional treatments. The trial did not include patients who relapsed after initial treatment with PegIFN/RBV.

In this double-blind, randomized, placebo-controlled trial, 288 treatment-experienced GT-1 HCV patients were randomized (2:1:1) to receive either:

  • BI 201335 240mg QD with a three-day LI of PegIFN/RBV;
  • BI 201335 240mg QD plus PegIFN/RBV without LI; or
  • BI 201335 240mg twice-daily (BID) with a three-day LI of PegIFN/RBV

  • In each group, patients were given BI 201335 for 24 weeks in combination with PegIFN/RBV, which was given for 24 or 48 weeks.

    Patients in the two BI 201335 QD groups who achieved eRVR were re-randomized to either stop all treatment at Week 24 or continue PegIFN/RBV until Week 48.

    Treatment Outcomes in SILEN-C2 (Treatment-Experienced Patients)240mg
    QD/LI
    (N=142)240mg
    QD
    (N=76)240mg
    BID/LI
    (N=70)eRVR, %

    43

    45

    47Overall SVR, %

    28

    41

    31Breakthrough*, %

    25

    28

    17Relapse**, %

    25

    9

    19*Rebound on treatment with BI 20133
    '/>"/>

    SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
    2. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
    3. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
    4. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
    5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    6. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
    7. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
    8. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
    9. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
    10. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
    11. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/22/2014)... SPRINGS, Colo. , Aug. 22, 2014 /PRNewswire/ ... specializing in cannabis formulation-based drug development and related ... UFCM iCare,s third international medical cannabis conference taking ... Strasbourg, France , on October 22, ... with other stakeholders, such as researchers, health professionals, ...
    (Date:8/22/2014)... , Aug. 22, 2014  WaferGen Bio-systems, Inc. ... public offering of units of common stock and warrants ... proceeds of $20 million, prior to deducting underwriting discounts ... The shares and warrants are immediately separable and will ... expected to begin trading on The NASDAQ Stock Market ...
    (Date:8/21/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... women,s health, has appointed Holly B. Bauzon ... Ms. Bauzon has a proven track record in ... laboratory services companies. She has more than 20 years ... she held the position of Director, Lab Services Sales ...
    Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
    ... ALTO, Calif., Nov. 3, 2011 Telik, Inc. (Nasdaq: ... million, or $0.05 per share, for the third quarter ended ... million, or $0.09 per share, for the comparable period in ... total operating costs and expenses were $2.9 million, compared with $4.7 ...
    ... Aoxing Pharmaceutical (NYSE Amex: AXN ) ... research, development, manufacturing and distribution of narcotic, pain-management, ... operating subsidiary in China, Hebei Aoxing Pharmaceutical Group ... million RMB (approximately $315,000) from the Industry and ...
    Cached Medicine Technology:Telik Announces Third Quarter 2011 Financial Results 2Aoxing Pharmaceutical Company Announces Special Funding From Hebei Province in China 2Aoxing Pharmaceutical Company Announces Special Funding From Hebei Province in China 3
    (Date:8/23/2014)... Professional kitchen employees, prospective chefs and food industry ... Food Safety Certification exams thanks to the free ... Dynamic Path announced the release of its Food Safety ... questions for culinary industry students and professionals. , ... the ServSafe® Food Safety Certification, National Registry of Food ...
    (Date:8/23/2014)... 23, 2014 Young adults in Athens, GA who ... should pick up the phone and call the new helpline which ... addict . , Troubled Teen Athens is a wonderful resource ... finally take the necessary steps to end substance abuse once and ... to go to friends or peers when really they should put ...
    (Date:8/23/2014)... 2014 Youth substance abuse is a ... different in Houston, TX. Substance abuse can happen to ... drug and alcohol dependency in higher numbers than ever ... substance abuse, but don’t know where to find professional ... be a challenge because most treatment options are designed ...
    (Date:8/23/2014)... Holly Springs, NC (PRWEB) August 23, 2014 ... issues facing young people in Holly Springs, NC. Countless adolescents ... on a regular basis. Unfortunately, many never receive professional ... and young adults on where to get help. Troubled Teens ... difference in the lives of local teenage alcohol abusers ...
    (Date:8/22/2014)... Search Engine Optimization is needed to ... search engines and get more audience and sales. ... many Linux hosting suppliers and announced that HostGator.com ... recommended Linux hosting suppliers for webmasters from the ... high quality Linux hosting (including VPS and cloud ...
    Breaking Medicine News(10 mins):Health News:Food Handler Safety Certification Made Easy with Dynamic Path 2Health News:Teenagers in Athens, GA are Locating Addiction Recovery Thanks to New Helpline 2Health News:New Houston Hotline Assisting Juveniles in Locating Dependable Rehabilitation Help 2Health News:New Helpline Provides Teen Drug & Alcohol Recovery Information in Holly Springs, NC 2Health News:Top10BestSEOHosting.com Announces Best Cheap Hosting Suppliers Of This Summer 2
    ... put on over Christmas, you may be interested in knowing that ... likelihood of regaining weight after dieting. A new study confirms that ... ghrelin are more likely to put the centimetres they lost back ... after sticking to a slimming diet, have regained the kilos lost ...
    ... a bacterium inside the worm acts as a ,disguise, for ... in an ineffective way. The bacteria protect the worm ... removed with antibiotics, the immune system responds appropriately, releasing cells, ... are successful against the parasite, but the long treatment regime ...
    ... Steven Reinberg HealthDay Reporter , TUESDAY, Jan. ... inflammation, such as Celebrex and Advil, can raise ... review of existing research suggests. Swiss researchers analyzed ... drugs (NSAIDs), as these medications are called, and concluded ...
    ... By Serena Gordon HealthDay Reporter , TUESDAY, ... who have prostate cancer surgery experience urinary incontinence afterward, ... lessen bladder control problems for a significant number of ... including fluid management, pelvic exercises and bladder control techniques ...
    ... TUESDAY, Jan. 11 (HealthDay News) -- The steady, long-term decline ... has been an alarming increase in the number of abortion ... rate in 2008 was 19.6 per 1,000 women aged 15 ... 29.3 per 1,000 women, according to the nonprofit Guttmacher Institute, ...
    ... on December 2, 2010, Healthy People 2020 is an ... all Americans. A key component, Education for Health, is ... goals. Formulated by the Healthy People Curriculum Task Force, ... a vehicle for promoting the discussion and progress that ...
    Cached Medicine News:Health News:'Yo-yo' effect of slimming diets explained 2Health News:Study sheds new light on river blindness parasite 2Health News:Certain Painkillers Appear to Boost Odds for Heart Attack 2Health News:Certain Painkillers Appear to Boost Odds for Heart Attack 3Health News:Therapy May Help Cut Incontinence After Prostate Surgery 2Health News:Therapy May Help Cut Incontinence After Prostate Surgery 3Health News:Decline in U.S. Abortion Rate Stalls, Report Finds 2Health News:10-year roadmap for reaching public health education goals 2Health News:10-year roadmap for reaching public health education goals 3Health News:10-year roadmap for reaching public health education goals 4
    ... Vibratome comes standard with a square ... blocks are utilized for mounting specimens ... vice. The blocks are annodized ... can be reused. They are ...
    This is a perfect tool for retrieving free floating sections from the Vibratome bath....
    ... an optional component available for Vibratome ... plugs into the back of all ... a selector switch. Once activated, ... initiating a sectioning sequence and reversing ...
    ... 900R is a modular peltier refrigeration system that ... It utilizes the Deluxe bath system as standard ... repeatable specimen orientation. The unit will chill ... degree centigrade to ambient temperature. It will ...
    Medicine Products: